Clinical Trials
Riverside is here for you during the COVID-19 outbreak.

For more information, please click here.

DCP-001

DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP) 
 

DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

 

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations.

The data collected will be used by:

  1. NCI to evaluate the overall performance of the community program (NCORP)
  2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial
  3. Researchers to improve the design of current and future studies
  4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

 

Principal Investigator

William MacLaughlin, MD

Contact

Ora Mae Jackson, RN, OCN
757-534-5565
[email protected]

Locations

All Peninsula Cancer Institute and Cancer Specialists of Tidewater sites

Status

Recruiting

Category

Oncology

Study #

n/a